Status:
COMPLETED
To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion
Lead Sponsor:
Acrux DDS Pty Ltd
Conditions:
Hypogonadism
Eligibility:
FEMALE
18-45 years
Phase:
PHASE1
Brief Summary
Testosterone replacement treatment is the most effective way of treating hypogonadism in men. Acrux has a propriety testosterone replacement product, Testosterone MD-Lotion and this study will evalua...
Eligibility Criteria
Inclusion
- Healthy premenopausal female subjects ≥18 and ≤45 years of age with qualifying general medical health.
Exclusion
- Disqualifying concurrent condition or allergy/sensitivity to testosterone replacement therapy.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2009
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00857168
Start Date
January 1 2009
End Date
April 1 2009
Last Update
October 14 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QPharm Pty Ltd
Brisbane, Queensland, Australia